MENU
+Compare
CRDL
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$1.01
Change
-$0.00 (-0.00%)
Capitalization
124.33M

CRDL Cardiol Therapeutics Forecast, Technical & Fundamental Analysis

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more

CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CRDL with price predictions
Apr 17, 2025

CRDL in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 26, 2025

CRDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where CRDL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CRDL's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 14, 2025. You may want to consider a long position or call options on CRDL as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRDL just turned positive on April 11, 2025. Looking at past instances where CRDL's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDL advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRDL entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CRDL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.845) is normal, around the industry mean (60.843). P/E Ratio (0.000) is within average values for comparable stocks, (89.540). CRDL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. CRDL's P/S Ratio (1000.000) is very high in comparison to the industry average of (20.019).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CRDL is expected to report earnings to rise 30.23% to -9 cents per share on May 20

Cardiol Therapeutics CRDL Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.05
Q2'24
Beat
by $0.03
Q1'24
Missed
by $0.01
The last earnings report on March 27 showed earnings per share of -6 cents, beating the estimate of -9 cents. With 124.72K shares outstanding, the current market capitalization sits at 124.33M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2265 Upper Middle Road East
Phone
+1 289 910-0850
Employees
22
Web
https://www.cardiolrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

CRDL and Stocks

Correlation & Price change

A.I.dvisor tells us that CRDL and CGC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
N/A
CGC - CRDL
33%
Poorly correlated
+0.85%
ACB - CRDL
32%
Poorly correlated
+2.30%
OGI - CRDL
32%
Poorly correlated
+2.88%
TLRY - CRDL
30%
Poorly correlated
-5.42%
CRON - CRDL
30%
Poorly correlated
N/A
More